Table 1.
Antimicrobial susceptibility profile of L. ivanovii and E. cloacae isolated from ready-to-eat foods.
| Number (%) | |||
|---|---|---|---|
| Antibiotic | L. ivanovii (n = 51) | ||
| S | I | R | |
| Chloramphenicol (30 µg) | 51 (100) | 0 (0) | 0 (0) |
| Kanamycin (30 µg) | 21 (39) | 19 (37) | 11 (22) |
| Amoxacillin (20 µg) | 3 (6) | 0 (0) | 48 (94) |
| Penicillin G (10 units) | 0 (0) | 0 (0) | 51 (100) |
| Vancomycin (30 µg) | 0 (0) | 0 (0) | 51 (100) |
| Ciprofloxacin (5 µg) | 51 (100) | 0 (0) | 0 (0) |
| Streptomycin (10 µg) | 51 (100) | 0 (0) | 0 (0) |
| Trimeth/Sulfamethoxazole (1.25 µg) | 51 (100) | 0 (0) | 0 (0) |
| Nalidixic acid (30 µg) | 50 (98) | 1 (2) | 0 (0) |
| Trimethoprim (5 µg) | 42 (82) | 4 (8) | 5 (10) |
| Erythromycin (15 µg) | 0 (0) | 0 (0) | 51 (100) |
| Neomycin (30 µg) | 20 (39) | 24 (47) | 7 (14) |
| Tetracycline (30 µg) | 28 (55) | 0 (0) | 23 (45) |
| Ampicillin (10 µg) | 23 (45) | 5 (10) | 23 (45) |
| Gentamicin (10 µg) | 50 (98) | 1 (2) | 0 (0) |
| Antibiotic | Enterobacter cloacae (n = 33) | ||
| S | I | R | |
| Chloramphenicol (30 µg) | 30 (91) | 2 (6) | 1 (3) |
| Kanamycin (30 µg) | 27 (82) | 3 (9) | 3 (9) |
| Amoxacillin (20 µg) | 0 (0) | 0 (0) | 33 (100) |
| Penicillin G (10 units) | 0 (0) | 0 (0) | 33 (100) |
| Vancomycin (30 µg) | 0 (0) | 0 (0) | 33 (100) |
| Ciprofloxacin (5 µg) | 33 (100) | 0 (0) | 0 (0) |
| Streptomycin (10 µg) | 31 (94) | 2 (6) | 0 (0) |
| Trimeth/Sulfamethoxazole (1.25 µg) | 26 (79) | 0 (0) | 7 (21) |
| Nalidixic acid (30 µg) | 32 (97) | 1(3) | 0 (0) |
| Trimethoprim (5 µg) | 26 (78) | 0 (0) | 7 (21) |
| Erythromycin (15 µg) | 0 (0) | 0 (0) | 33 (100) |
| Neomycin (30 µg) | 15 (45) | 13 (39) | 5 (15) |
| Tetracycline (30 µg) | 14 (42) | 0 (0) | 19 (58) |
| Ampicillin (10 µg) | 0 (0) | 7 (21) | 26 (79) |
| Gentamicin (10 µg) | 30 (91) | 1 (3) | 2 (6) |
S, sensitive; I, intermediate; R, resistant.